The rationale and design of the Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure (ATOMIC-AHF) study: a phase 2, cohort study of a novel cardiac myosin activator
Publication
, Journal Article
Teerlink, JR; Felker, GM; Mc Murray, JJV; Kim, JB; Knusel, B; Lei, L; Malik, FI; Wasserman, SM
Published in: EUROPEAN JOURNAL OF HEART FAILURE
May 1, 2013
Duke Scholars
Published In
EUROPEAN JOURNAL OF HEART FAILURE
EISSN
1879-0844
ISSN
1388-9842
Publication Date
May 1, 2013
Volume
12
Start / End Page
S308 / S309
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Teerlink, J. R., Felker, G. M., Mc Murray, J. J. V., Kim, J. B., Knusel, B., Lei, L., … Wasserman, S. M. (2013). The rationale and design of the Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure (ATOMIC-AHF) study: a phase 2, cohort study of a novel cardiac myosin activator. EUROPEAN JOURNAL OF HEART FAILURE, 12, S308–S309.
Teerlink, J. R., G. M. Felker, J. J. V. Mc Murray, J. B. Kim, B. Knusel, L. Lei, F. I. Malik, and S. M. Wasserman. “The rationale and design of the Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure (ATOMIC-AHF) study: a phase 2, cohort study of a novel cardiac myosin activator.” EUROPEAN JOURNAL OF HEART FAILURE 12 (May 1, 2013): S308–9.
Teerlink JR, Felker GM, Mc Murray JJV, Kim JB, Knusel B, Lei L, et al. The rationale and design of the Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure (ATOMIC-AHF) study: a phase 2, cohort study of a novel cardiac myosin activator. EUROPEAN JOURNAL OF HEART FAILURE. 2013 May 1;12:S308–9.
Teerlink, J. R., et al. “The rationale and design of the Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure (ATOMIC-AHF) study: a phase 2, cohort study of a novel cardiac myosin activator.” EUROPEAN JOURNAL OF HEART FAILURE, vol. 12, WILEY-BLACKWELL, May 2013, pp. S308–09.
Teerlink JR, Felker GM, Mc Murray JJV, Kim JB, Knusel B, Lei L, Malik FI, Wasserman SM. The rationale and design of the Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure (ATOMIC-AHF) study: a phase 2, cohort study of a novel cardiac myosin activator. EUROPEAN JOURNAL OF HEART FAILURE. WILEY-BLACKWELL; 2013 May 1;12:S308–S309.
Published In
EUROPEAN JOURNAL OF HEART FAILURE
EISSN
1879-0844
ISSN
1388-9842
Publication Date
May 1, 2013
Volume
12
Start / End Page
S308 / S309
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology